Search

We describe the case of a previously well 19-month-old boy who presented with an acute Epstein-Barr virus infection and a prolonged activated partial thromboplastin time (APTT) associated with the presence of a transient lupus anticoagulant (LA). The boy had an excellent outcome, with gradual normalization of the APTT and disappearance of the LA.

Unlabelled: Orotracheal intubation causes cervical spine (C-spine) extension and potential (hypothetical) space available for the cord (SAC)-deformation. In the present study, we determined and compared the changes induced by conventional- and balloon laryngoscopy-guided orolaryngeal intubation in the upper C-spine's osseous unit-orientation, segmental angulation, segmental SAC-sagittal surface areas (SSAs), segmental/total posterior SAC-aspect, and segmental SAC-width. Eight healthy volunteers were enrolled. A set of neutral head position (baseline)- and two sets of intubation-lateral C-spine radiographs were obtained. Relative to baseline, both intubation techniques induced significant changes in the occiput (OCC)-, third cervical vertebra (C3)-, C4-, and C5-orientation, the OCC-C1-segmental angulation, all the segmental SAC-SSAs, and the OCC-C1-, and C1-2-posterior SAC-aspect (P < 0.05 to < 0.001); conventional intubation caused additional significant changes in C2-orientation, total (OCC through C5)-posterior SAC-aspect, and OCC-C1-SAC-width (P < 0.05 to < 0.001). Relative to conventional intubation, balloon-assisted intubation caused less change in C3-orientation and C2-3-SAC-width (P < 0.05), and less reduction in OCC-C1-, C1-2-, and C4-5-SAC-SSAs (P < 0.05 to < 0.01). Orotracheal intubation should be cautiously performed in patients with space-occupying upper-C-spine-SAC lesions, even if there is no concomitant osseous/ligamentous pathology. In such cases, balloon laryngoscopy may be chosen over the conventional technique, because it causes less SAC deformation., Implications: This study shows that direct laryngoscopy-guided orotracheal intubation causes deformation of the upper cervical space available for the cord, even in the absence of cervical spine instability. These effects are attenuated with balloon laryngoscopy, and thus, its use is recommended in patients with space-occupying lesions within the spinal canal.

We compared laryngeal aperture (LA) exposure and endotracheal intubation difficulty scale (IDS) scores between balloon-assisted and conventional laryngoscopy. Thirty-two anesthetized and paralyzed elective surgery patients underwent laryngoscopy with a standard number 4 and a modified number 4 curved blade carrying a 6F Fogarty catheter. The balloon laryngoscopy technique included modified blade tip insertion into the vallecula, Fogarty catheter balloon inflation with 2 mL of air, and blade elevation until LA exposure maximization. On maximal LA exposure with both blades, the LA views were videotaped with a camcorder aligned to blade light source and the exposed LA areas measured electronically. The IDS scores were determined on passing the tip of an endotracheal tube through the vocal cords. The patient head position, the angle of laryngoscope handle elevation, and the time available for airway instrumentation were standardized. The data from 27 patients were analyzed. The exposed LA areas were significantly larger with balloon laryngoscopy than conventional (median, interquartile range: 0.94, 0.65-1.80 cm(2) vs. 0.52, 0.39-1.46 cm(2) respectively) (P = 0.027), and the IDS scores lesser (median, interquartile range: 0, 0-1 vs. 1, 0-2 respectively) (P = 0.012). We concluded that balloon laryngoscopy facilitates elective airway management.

Background/aims: The therapeutic experience of interferon-alpha therapy against hepatitis D virus infection in affected children is rather limited. For this reason, we conducted a retrospective study (duration: 1991-1995) in order to evaluate the efficacy and the safety of interferon-alpha in children suffering from chronic hepatitis D in Northwestern Greece., Methodology: Seven children who were found to be infected with HDV in a total of 324 children seropositive for hepatitis B virus infection during the 5-year period of the study were treated with interferon-alpha, 3 x 10(6) U/m2 body surface area, intramuscularly or subcutaneously, 3 times weekly for 1 year (after an informed consent obtained from their parents). Patients were assessed monthly by hematological serological and biochemical tests. Clinical progress, levels of serum alanine aminotransferase, hepatitis D ribonucleic acid (HDV-RNA) and hepatitis B deoxyribonucleic acid (HBV-DNA), seroconversion of hepatitis B surface antigen (HBsAg) and Hepatitis Be Antigen (HBeAg) and liver histology were used as response criteria., Results: Posttreatment alanine transferase levels were significantly reduced (P < 0.05) but Immunoglobulin M and total anti-hepatitis D virus (anti-HDV) antibodies remained positive in all, while hepatitis D ribonucleic acid persisted positive in 4 cases. In addition, no seroconversion of HBsAg or HBeAg was noted and the liver histology progress was disappointing. Side effects including mild fever, arthralgias and malaise and reversible neutropenia and thrombocytopenia were common, but not particularly disturbing. Nevertheless, the children remained fully active on treatment, felt well and attended school. Initially 4 children had been below the 10th percentile for weight and height. All thrived during treatment and two crossed above the 10th percentile indicating height velocity and body mass index increase., Conclusions: The administration of regular interferon-alpha doses for treating children with chronic hepatitis D was safe as attested by the mild side effects and the objective clinical criteria regarding their growth, but relatively ineffective. Although the prevalence of hepatitis D virus infection is now generally decreased, this study indirectly indicates that more effective agents and new approaches at the molecular level of the hepatitis D virus genome are urgently warranted for its control in individuals already infected with the virus. Finally, the poor therapeutic results in the present study further enhance the necessity of the expanded vaccination against Hepatitis B virus according to the World Health Organization's recommendations.